SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012634
Filing Date
2019-08-14
Accepted
2019-08-14 17:15:35
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 953895
2 ex4-1.htm EX-4.1 34975
3 ex10-1.htm EX-10.1 299303
4 ex10-2.htm EX-10.2 121555
5 ex10-3.htm EX-10.3 60416
6 ex31.htm EX-31 36961
7 ex32.htm EX-32 8816
  Complete submission text file 0001493152-19-012634.txt   5347506

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE age-20190630.xml EX-101.INS 1085890
9 XBRL SCHEMA FILE age-20190630.xsd EX-101.SCH 39784
10 XBRL CALCULATION FILE age-20190630_cal.xml EX-101.CAL 62092
11 XBRL DEFINITION FILE age-20190630_def.xml EX-101.DEF 178246
12 XBRL LABEL FILE age-20190630_lab.xml EX-101.LAB 290647
13 XBRL PRESENTATION FILE age-20190630_pre.xml EX-101.PRE 252284
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 191027581
SIC: 2834 Pharmaceutical Preparations